A detailed history of Abn Amro Investment Solutions transactions in Eli Lilly & CO stock. As of the latest transaction made, Abn Amro Investment Solutions holds 80,993 shares of LLY stock, worth $83 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
80,993
Previous 93,373 13.26%
Holding current value
$83 Million
Previous $72.8 Billion 15.1%
% of portfolio
1.27%
Previous 1.46%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

SELL
$625.65 - $812.69 $7.75 Million - $10.1 Million
-12,380 Reduced 13.26%
80,993 $61.8 Billion
Q2 2025

Aug 08, 2025

BUY
$713.71 - $898.95 $66.6 Million - $83.9 Million
93,373 New
93,373 $72.8 Billion
Q1 2025

Aug 27, 2025

SELL
$725.72 - $929.72 $2.47 Million - $3.17 Million
-3,408 Reduced 3.65%
89,965 $74.3 Billion
Q4 2024

Sep 04, 2025

BUY
$727.2 - $932.06 $50.7 Million - $64.9 Million
69,676 Added 522.23%
83,018 $64.1 Billion
Q3 2024

Sep 04, 2025

SELL
$772.14 - $960.02 $61.8 Million - $76.8 Million
-80,031 Reduced 85.71%
13,342 $11.8 Billion
Q2 2024

Sep 04, 2025

SELL
$724.87 - $909.04 $57.5 Million - $72.1 Million
-79,342 Reduced 84.97%
14,031 $12.7 Billion
Q1 2024

Sep 05, 2025

BUY
$592.2 - $792.28 $87,645 - $117,257
148 Added 1.06%
14,046 $10.9 Billion
Q4 2023

Sep 05, 2025

SELL
$525.19 - $619.13 $702,704 - $828,395
-1,338 Reduced 8.78%
13,898 $8.1 Billion
Q3 2023

Nov 07, 2025

SELL
$434.7 - $599.3 $28.6 Million - $39.4 Million
-65,757 Reduced 81.19%
15,236 $8.18 Billion
Q3 2023

Nov 03, 2025

SELL
$434.7 - $599.3 $5.38 Million - $7.42 Million
-12,380 Reduced 13.26%
80,993 $61.8 Billion
Q3 2023

Sep 05, 2025

BUY
$434.7 - $599.3 $2.61 Million - $3.6 Million
6,014 Added 65.21%
15,236 $8.18 Billion
Q2 2023

Sep 05, 2025

SELL
$350.74 - $468.98 $194,309 - $259,814
-554 Reduced 5.67%
9,222 $4.32 Billion
Q1 2023

Sep 05, 2025

SELL
$310.63 - $364.82 $26 Million - $30.5 Million
-83,597 Reduced 89.53%
9,776 $3.36 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $974B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Abn Amro Investment Solutions Portfolio

Follow Abn Amro Investment Solutions and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

News

Stay updated on Abn Amro Investment Solutions with notifications on news.